Report Detail
Global Biosimilar Monoclonal Antibodies Sales Market Report 2019
- RnM2786375 |
- 22 January, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
The global Biosimilar Monoclonal Antibodies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Biosimilar Monoclonal Antibodies market status and forecast, categorizes the global Biosimilar Monoclonal Antibodies market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Major manufacturers covered in this report
ProMab Biotechnologies
Allergan plc
Abbott
BioXpress Therapeutics
Bayer
Bio Farma
Merck
Therapeutics
Biocon
Boehringer Ingelheim
Celltrion Inc.
Coherus BioSciences Inc.
Zydus-Cadila
Genor BioPharma
Intas Pharmaceuticals
Novartis
Pfizer
Reliance Life Sciences
In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Segment by Type
Infliximab
Rituximab
Abciximab
Trastuzumab
Adalimumab
Bevacizumab
Segment by Application
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
Table of Contents
Global Biosimilar Monoclonal Antibodies Sales Market Report 2019
1 Biosimilar Monoclonal Antibodies Market Overview
- 1.1 Biosimilar Monoclonal AntibodiesProduct Overview
- 1.2 Biosimilar Monoclonal Antibodies Segment by Type
- 1.2.1 Global Biosimilar Monoclonal Antibodies Sales Comparison by Types (2014-2025)
- 1.2.2 Infliximab
- 1.2.3 Rituximab
- 1.2.4 Abciximab
- 1.2.5 Trastuzumab
- 1.2.6 Adalimumab
- 1.2.7 Bevacizumab
- 1.3 Biosimilar Monoclonal Antibodies Segment by Application
- 1.3.1 Global Biosimilar Monoclonal Antibodies Sales Comparison by Application (2014-2025)
- 1.3.1 Oncology
- 1.3.2 Chronic and Autoimmune Diseases
- 1.3.3 Growth Hormone Deficiency
- 1.3.4 Infectious Diseases
- 1.3.5 Others
- 1.4 Biosimilar Monoclonal Antibodies Market by Region
- 1.4.1 Global Biosimilar Monoclonal Antibodies Revenue Comparison by Region (2014-2025)
- 1.4.2 United States Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.4.3 Europe Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.4.4 China Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.4.5 Japan Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.4.6 Southeast Asia Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.4.7 India Biosimilar Monoclonal Antibodies Status and Prospect (2014-2025)
- 1.5 Global Biosimilar Monoclonal Antibodies Sales and Revenue (2014-2025)
- 1.5.1 Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2025)
- 1.5.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2014-2025)
2 Biosimilar Monoclonal Antibodies by Company, Region, Type and Application
- 2.1 Global Biosimilar Monoclonal Antibodies Market Competition by Companies
- 2.1.1 Global Biosimilar Monoclonal Antibodies Sales Market Share of Key Companies (2014-2019)
- 2.1.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2014-2019)
- 2.2 Global Biosimilar Monoclonal Antibodies Sales and Revenue by Region
- 2.2.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2014-2019)
- 2.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2014-2019)
- 2.3 Global Biosimilar Monoclonal Antibodies Sales and Revenue by Type
- 2.3.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2014-2019)
- 2.3.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2014-2019)
- 2.4 Global Biosimilar Monoclonal Antibodies Sales by Application
3 United States Biosimilar Monoclonal Antibodies Sales, Revenue and Price
- 3.1 United States Biosimilar Monoclonal Antibodies Sales and Revenue (2014-2019)
- 3.1.1 United States Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019)
- 3.1.2 United States Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019)
- 3.1.3 United States Biosimilar Monoclonal Antibodies Price Trend (2014-2019)
- 3.2 United States Biosimilar Monoclonal Antibodies Sales Market Share by Company
- 3.3 United States Biosimilar Monoclonal Antibodies Sales Market Share by Type
- 3.4 United States Biosimilar Monoclonal Antibodies Sales Market Share by Application
4 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Price
- 4.1 Europe Biosimilar Monoclonal Antibodies Sales and Value (2014-2019)
- 4.1.1 Europe Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019)
- 4.1.2 Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019)
- 4.1.3 Europe Biosimilar Monoclonal Antibodies Price Trend (2014-2019)
- 4.2 Europe Biosimilar Monoclonal Antibodies Sales Market Share by Company
- 4.3 Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type
- 4.4 Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application
5 China Biosimilar Monoclonal Antibodies Sales, Revenue and Price
- 5.1 China Biosimilar Monoclonal Antibodies Sales and Revenue (2014-2019)
- 5.1.1 China Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019)
- 5.1.2 China Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019)
- 5.1.3 China Biosimilar Monoclonal Antibodies Price Trend (2014-2019)
- 5.2 China Biosimilar Monoclonal Antibodies Sales Market Share by Company
- 5.3 China Biosimilar Monoclonal Antibodies Sales Market Share by Type
- 5.4 China Biosimilar Monoclonal Antibodies Sales Market Share by Application
6 Japan Biosimilar Monoclonal Antibodies Sales, Revenue and Price
- 6.1 Japan Biosimilar Monoclonal Antibodies Sales and Value (2014-2019)
- 6.1.1 Japan Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019)
- 6.1.2 Japan Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019)
- 6.1.3 Japan Biosimilar Monoclonal Antibodies Price Trend (2014-2019)
- 6.2 Japan Biosimilar Monoclonal Antibodies Sales Market Share by Company
- 6.3 Japan Biosimilar Monoclonal Antibodies Sales Market Share by Type
- 6.4 Japan Biosimilar Monoclonal Antibodies Sales Market Share by Application
7 Southeast Asia Biosimilar Monoclonal Antibodies Sales, Revenue and Price
- 7.1 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Value (2014-2019)
- 7.1.1 Southeast Asia Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019)
- 7.1.2 Southeast Asia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019)
- 7.1.3 Southeast Asia Biosimilar Monoclonal Antibodies Price Trend (2014-2019)
- 7.2 Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Company
- 7.3 Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Type
- 7.4 Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Application
8 India Biosimilar Monoclonal Antibodies Sales, Revenue and Price
- 8.1 India Biosimilar Monoclonal Antibodies Sales and Value (2014-2019)
- 8.1.1 India Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019)
- 8.1.2 India Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019)
- 8.1.3 India Biosimilar Monoclonal Antibodies Price Trend (2014-2019)
- 8.2 India Biosimilar Monoclonal Antibodies Sales Market Share by Company
- 8.3 India Biosimilar Monoclonal Antibodies Sales Market Share by Type
- 8.4 India Biosimilar Monoclonal Antibodies Sales Market Share by Application
9 Company Profiles and Key Figures in Biosimilar Monoclonal Antibodies Business
- 9.1 ProMab Biotechnologies
- 9.1.1 ProMab Biotechnologies Biosimilar Monoclonal Antibodies Production Sites and Area Served
- 9.1.2 Biosimilar Monoclonal Antibodies Specification and Application
- 9.1.3 ProMab Biotechnologies Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.1.4 Main Business and Markets Served
- 9.2 Allergan plc
- 9.2.1 Allergan plc Biosimilar Monoclonal Antibodies Production Sites and Area Served
- 9.2.2 Biosimilar Monoclonal Antibodies Specification and Application
- 9.2.3 Allergan plc Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.2.4 Main Business and Markets Served
- 9.3 Abbott
- 9.3.1 Abbott Biosimilar Monoclonal Antibodies Production Sites and Area Served
- 9.3.2 Biosimilar Monoclonal Antibodies Specification and Application
- 9.3.3 Abbott Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.3.4 Main Business and Markets Served
- 9.4 BioXpress Therapeutics
- 9.4.1 BioXpress Therapeutics Biosimilar Monoclonal Antibodies Production Sites and Area Served
- 9.4.2 Biosimilar Monoclonal Antibodies Specification and Application
- 9.4.3 BioXpress Therapeutics Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.4.4 Main Business and Markets Served
- 9.5 Bayer
- 9.5.1 Bayer Biosimilar Monoclonal Antibodies Production Sites and Area Served
- 9.5.2 Biosimilar Monoclonal Antibodies Specification and Application
- 9.5.3 Bayer Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.5.4 Main Business and Markets Served
- 9.6 Bio Farma
- 9.6.1 Bio Farma Biosimilar Monoclonal Antibodies Production Sites and Area Served
- 9.6.2 Biosimilar Monoclonal Antibodies Specification and Application
- 9.6.3 Bio Farma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.6.4 Main Business and Markets Served
- 9.7 Merck
- 9.7.1 Merck Production Sites and Area Served
- 9.7.2 Biosimilar Monoclonal Antibodies Specification and Application
- 9.7.3 Merck Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.7.4 Main Business and Markets Served
- 9.8 Therapeutics
- 9.8.1 Therapeutics Biosimilar Monoclonal Antibodies Production Sites and Area Served
- 9.8.2 Biosimilar Monoclonal Antibodies Specification and Application
- 9.8.3 Therapeutics Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.8.4 Main Business and Markets Served
- 9.9 Biocon
- 9.9.1 Biocon Biosimilar Monoclonal Antibodies Production Sites and Area Served
- 9.9.2 Biosimilar Monoclonal Antibodies Specification and Application
- 9.9.3 Biocon Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.9.4 Main Business and Markets Served
- 9.10 Boehringer Ingelheim
- 9.10.1 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Production Sites and Area Served
- 9.10.2 Biosimilar Monoclonal Antibodies Specification and Application
- 9.10.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.10.4 Main Business and Markets Served
- 9.11 Celltrion Inc.
- 9.12 Coherus BioSciences Inc.
- 9.13 Zydus-Cadila
- 9.14 Genor BioPharma
- 9.15 Intas Pharmaceuticals
- 9.16 Novartis
- 9.17 Pfizer
- 9.18 Reliance Life Sciences
10 Biosimilar Monoclonal Antibodies Maufacturing Cost Analysis
- 10.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
- 10.1.1 Key Raw Materials
- 10.1.2 Key Raw Materials Price Trend
- 10.1.3 Key Suppliers of Raw Materials
- 10.2 Proportion of Manufacturing Cost Structure
- 10.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
- 10.4 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
11 Marketing Channel, Distributors and Customers
- 11.1 Marketing Channel
- 11.1.1 Direct Marketing
- 11.1.2 Indirect Marketing
- 11.2 Biosimilar Monoclonal Antibodies Distributors List
- 11.3 Biosimilar Monoclonal Antibodies Customers
12 Market Dynamics
- 12.1 Market Trends
- 12.2 Opportunities
- 12.3 Market Drivers
- 12.4 Challenges
- 12.5 Influence Factors
13 Biosimilar Monoclonal Antibodies Market Forecast
- 13.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Price Forecast
- 13.1.1 Global Biosimilar Monoclonal Antibodies Sales Growth Forecast (2019-2025)
- 13.1.2 Global Biosimilar Monoclonal Antibodies Revenue Growth Forecast (2019-2025)
- 13.1.3 Global Biosimilar Monoclonal Antibodies Price Trend Forecast (2019-2025)
- 13.2 Global Biosimilar Monoclonal Antibodies Forecast by Region
- 13.2.1 Global Biosimilar Monoclonal Antibodies Sales Growth Forecast by Region (2019-2025)
- 13.2.2 Global Biosimilar Monoclonal Antibodies Revenue Growth Forecast by Region (2019-2025)
- 13.2.3 United States Biosimilar Monoclonal Antibodies Sales, Revenue Growth Forecast (2019-2025)
- 13.2.4 Europe Biosimilar Monoclonal Antibodies Sales, Revenue Growth Forecast (2019-2025)
- 13.2.5 China Biosimilar Monoclonal Antibodies Sales, Revenue Growth Forecast (2019-2025)
- 13.2.6 Japan Biosimilar Monoclonal Antibodies Sales, Revenue Growth Forecast (2019-2025)
- 13.2.7 Southeast Asia Biosimilar Monoclonal Antibodies Sales, Revenue Growth Forecast (2019-2025)
- 13.2.8 India Biosimilar Monoclonal Antibodies Sales, Revenue Growth Forecast (2019-2025)
- 13.3 Global Biosimilar Monoclonal Antibodies Forecast by Type
- 13.3.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2019-2025)
- 13.3.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2019-2025)
- 13.3.3 Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2019-2025)
- 13.4 Global Biosimilar Monoclonal Antibodies Forecast by Application
14 Research Findings and Conclusion
15 Methodology and Data Source
- 15.1 Methodology/Research Approach
- 15.1.1 Research Programs/Design
- 15.1.2 Market Size Estimation
- 15.1.3 Market Breakdown and Data Triangulation
- 15.2 Data Source
- 15.2.1 Secondary Sources
- 15.2.2 Primary Sources
- 15.3 Author List
Summary:
Get latest Market Research Reports on Biosimilar Monoclonal Antibodies. Industry analysis & Market Report on Biosimilar Monoclonal Antibodies is a syndicated market report, published as Global Biosimilar Monoclonal Antibodies Sales Market Report 2019. It is complete Research Study and Industry Analysis of Biosimilar Monoclonal Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
